Showing results (1291-1300 of 1,309) with videos related to

Sort By:
Pageof 131
Cardio-Oncology (London, England)|December 9, 2020
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler, Jeanne M DeCara, Joerg Herrmann, et al.
Brain : a Journal of Neurology|December 20, 2021
Forecasting stroke-like episodes and outcomes in mitochondrial diseaseYi Shiau Ng, Nichola Z Lax, Alasdair P Blain, et al.
Lung Cancer (Amsterdam, Netherlands)|April 4, 2025
Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS studySara Lindberg, Vitali Grozman, Kristin Karlsson, et al.
Virchows Archiv : an International Journal of Pathology|June 17, 2023
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)Constanze Elfgen, Cornelia Leo, Rahel A Kubik-Huch, et al.
Ebiomedicine|March 7, 2018
MT-ND5 Mutation Exhibits Highly Variable Neurological Manifestations at Low Mutant LoadYi Shiau Ng, Nichola Z Lax, Paul Maddison, et al.
Annals of Neurology|March 22, 2025
Neuroimaging Biomarkers for Friedreich Ataxia: A Cross-Sectional Analysis of the TRACK-FA StudyNellie Georgiou-Karistianis, Louise A Corben, Eric F Lock, et al.
Plos One|November 21, 2022
A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocolNellie Georgiou-Karistianis, Louise A Corben, Kathrin Reetz, et al.
Nature Communications|July 19, 2022
[<sup>11</sup>C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's diseaseTharick A Pascoal, Mira Chamoun, Elad Lax, et al.
Nature|January 7, 2026
Albumin orchestrates a natural host defence mechanism against mucormycosisAntonis Pikoulas, Ioannis Morianos, Vassilis Nidris, et al.
American Journal of Clinical Pathology|June 12, 2020
Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal CancerGregory J Tsongalis, M Rabie Al Turkmani, Michael Suriawinata, et al.
Pageof 131